Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cancer, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Fallopian Tube Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Squamous Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• NM21-1480

Snippet

Sponsor: Numab Therapeutics AG | Conditions: Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-05-23